Updated Review
Published: December 28, 2020
Since our review was published, a more definitive trial of NP001 was conducted. This failed to show any benefit in slowing ALS progression. We therefore change our NP001 Trials grade from C to D. We would still like to see additional studies of the WF10 form of sodium chlorite.